Cited by 2Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsAdipokines, Inflammation, and Metabolic Diseases

Effect on insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator during weight loss in obese women with and without polycystic ovary syndrome

Open access
Cheang, Kai I., Sistrun, Sakita N., Morel, Kelley S., Nestler, John E.·2016·International Journal of Endocrinology

Abstract

Background.A deficiency of D-chiro-inositol-inositolphosphoglycan mediator (DCI-IPG) may contribute to insulin resistance in polycystic ovary syndrome (PCOS). Whether the relationship between impaired DCI-IPG release and insulin resistance is specific to PCOS rather than obesity is unknown. We assessed insulin-released DCI-IPG and its relationship to insulin sensitivity at baseline and after weight loss in obese women with and without PCOS.Methods.Obese PCOS ( n=16 ) and normal ( n=15 ) women underwent 8 weeks of a hypocaloric diet. The Matsuda index, area under the curve DCI-IPG ( AUCDCI-IPG ), AUCinsulin , and AUCDCI-IPG/AUCinsulin were measured during a 2 hr OGTT at baseline and 8 weeks.Results.PCOS women had lower AUCDCI-IPG/AUCinsulin at baseline and a significant relationship between AUCDCI-IPG/AUCinsulin and Matsuda index ( p=0.0003 ), which was not present in controls. Weight loss was similar between PCOS (−4.08 kg) and normal women (−4.29 kg, p=0.6281 ). Weight loss in PCOS women did not change the relationship between AUCDCI-IPG/AUCinsulin and Matsuda index ( p=0.0100 ), and this relationship remained absent in control women.Conclusion.The association between AUCDCI-IPG/AUCinsulin and insulin sensitivity was only found in PCOS but not in normal women, and this relationship was unaffected by weight loss. DCI and its messenger may contribute to insulin resistance in PCOS independent of obesity.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2016/7631804

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Three studies reported that there was no statistically significant difference in fasting glucose post-intervention between the two groups.

    “The majority of studies did not report whether there were between-group statistical significance, and three studies [35,43,44] reported that there was no statistically significant difference in fasting glucose post-intervention between the two groups (Table 4).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 32 · Cited by 2

Authors
Cheang, K. I., Sistrun, S. N., Morel, K. S., & Nestler, J. E.
Affiliations
  • Virginia Commonwealth University (US)
  • Carilion Clinic (US)
Corresponding author
Cheang, Kai I.
Venue
International Journal of Endocrinology
Publisher
Wiley
Published
2016
Volume
2016
Pages
1-7
ISSN
  • 1687-8337 (ISSN-L)
  • 1687-8345
OpenAlex
W2519135216
Cited by
2
References
32
Citations by year
2023: 1 · 2017: 1
FWCI
0.44
Type
journal article
Language
en
Open access
Locations
  • International Journal of Endocrinology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institutes of Health Grant (K23 K23HD049454, ULTR000058)
  • CTSA (K23 K23HD049454, ULTR000058)
  • National Center for Advancing Translational Sciences (K23 K23HD049454, ULTR000058)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
Keywords
D-chiro-inositol, insulin resistance, polycystic ovary syndrome, obesity, weight loss, insulin sensitivity, Matsuda index, hypocaloric diet, glucose tolerance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review